JP2019146492A - Method for inducing differentiation of induced pluripotent stem cells - Google Patents

Method for inducing differentiation of induced pluripotent stem cells Download PDF

Info

Publication number
JP2019146492A
JP2019146492A JP2018031705A JP2018031705A JP2019146492A JP 2019146492 A JP2019146492 A JP 2019146492A JP 2018031705 A JP2018031705 A JP 2018031705A JP 2018031705 A JP2018031705 A JP 2018031705A JP 2019146492 A JP2019146492 A JP 2019146492A
Authority
JP
Japan
Prior art keywords
pluripotent stem
stem cells
culture
induced pluripotent
alicyclic structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018031705A
Other languages
Japanese (ja)
Other versions
JP7035616B2 (en
Inventor
孝明 平野
Takaaki Hirano
孝明 平野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Nippon Zeon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zeon Co Ltd filed Critical Nippon Zeon Co Ltd
Priority to JP2018031705A priority Critical patent/JP7035616B2/en
Publication of JP2019146492A publication Critical patent/JP2019146492A/en
Application granted granted Critical
Publication of JP7035616B2 publication Critical patent/JP7035616B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

To provide differentiation induction methods capable of efficiently inducing differentiation of induced pluripotent stem cells into endoderm cells.SOLUTION: Provided is a method for inducing differentiation of induced pluripotent stem cells, comprising coating at least the culture surface of a culture vessel in which at least the culture surface is composed of an alicyclic structure-containing polymer, with a coating agent with a vitronectin concentration of 0.50 to 1.20 μg/ml; culturing induced pluripotent stem cells in the culture vessel subjected to the coating; and adhering the induced pluripotent stem cells to the culture surface to induce differentiation into endoderm cells.SELECTED DRAWING: None

Description

本発明は、人工多能性幹細胞(iPS細胞)の分化誘導方法に関し、特に人工多能性幹細胞から内胚葉細胞への分化誘導方法に関する。   The present invention relates to a method for inducing differentiation of induced pluripotent stem cells (iPS cells), and particularly to a method for inducing differentiation from induced pluripotent stem cells to endoderm cells.

人工多能性幹細胞の分化誘導においては、人工多能性幹細胞を浮遊培養することによって、三胚葉すべてに分化できる三次元の細胞塊である胚様体(embryoid body;EB)を形成する方法が一般的である。   In the induction of differentiation of induced pluripotent stem cells, there is a method of forming an embryoid body (EB) that is a three-dimensional cell cluster that can differentiate into all three germ layers by suspension culture of induced pluripotent stem cells. It is common.

国際公開第2015/199117号International Publication No.2015 / 199117 国際公開第2017/115706号International Publication No. 2017/115706 特開2017-018137号公報JP-A-2017-018137

Kazutoshi Takahashiら、「Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors」、2006、Cell、Volume 126、Issue 4、p663-676Kazutoshi Takahashi et al., `` Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors '', 2006, Cell, Volume 126, Issue 4, p663-676 Kazutoshi Takahashiら、「Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors」、2007、Cell、Volume 131、Issue 5、p861-872Kazutoshi Takahashi et al., `` Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors '', 2007, Cell, Volume 131, Issue 5, p861-872

しかし、この方法では、胚様体がすべての胚葉に分化可能であるため(非特許文献1、2)、目的の胚葉への分化を制御する必要がある。   However, in this method, since the embryoid body can be differentiated into all germ layers (Non-Patent Documents 1 and 2), it is necessary to control the differentiation into the target germ layer.

特許文献1および2には、胚様体を形成しない分化誘導の方法として、未分化細胞の分化誘導培養時に、当該未分化細胞が脂環構造含有重合体製成形体と接触すると、分化誘導が促進されることが記載されている。   In Patent Documents 1 and 2, as a method for inducing differentiation without forming an embryoid body, differentiation induction is performed when the undifferentiated cells come into contact with the alicyclic structure-containing polymer molded product during differentiation induction culture of undifferentiated cells. It is described that it is promoted.

ところで、未分化能を維持したまま人工多能性幹細胞を増殖させるためには、ゼラチン、ファイブロネクチン、ビトロネクチン、ラミニン、またはこれらの部分配列などの細胞外基質を含む溶液状のコート剤を培養容器内に入れて一定時間静置し、物理的にこれらを培養容器の内面に吸着させることよって、人工多能性幹細胞が培養容器に接着しやすくなるようにするのが一般的である(例えば、特許文献3)。   By the way, in order to proliferate induced pluripotent stem cells while maintaining undifferentiated ability, a solution-like coating agent containing an extracellular matrix such as gelatin, fibronectin, vitronectin, laminin, or a partial sequence thereof is used as a culture container. It is common to allow the artificial pluripotent stem cells to easily adhere to the culture container by allowing them to stand for a certain period of time and physically adsorbing them to the inner surface of the culture container (for example, Patent Document 3).

本発明は、上述した実情に鑑みてなされたものであり、人工多能性幹細胞を効率よく内胚葉細胞へと分化誘導できる分化誘導方法を提供することを目的とする。   The present invention has been made in view of the above-described circumstances, and an object thereof is to provide a differentiation induction method capable of efficiently inducing differentiation of induced pluripotent stem cells into endoderm cells.

かかる従来技術の下、本発明者は、人工多能性幹細胞を脂環構造含有重合体で構成される培養容器内で分化誘導し、高効率で内胚葉細胞を得るべく鋭意検討した結果、コート剤のビトロネクチンの濃度が一定範囲である場合に、脂環構造含有重合体で構成される培養容器に人工多能性幹細胞を接着させることができ、その結果、内胚葉細胞への高い分化誘導促進効果が得られることを見出し、本発明を完成するに至った。   Under such a conventional technique, the present inventors have conducted induction studies on differentiation of induced pluripotent stem cells in a culture vessel composed of an alicyclic structure-containing polymer to obtain endoderm cells with high efficiency. When the concentration of the vitronectin agent is within a certain range, artificial pluripotent stem cells can be attached to a culture vessel composed of a polymer containing an alicyclic structure, and as a result, high differentiation induction into endoderm cells is promoted The inventors have found that an effect can be obtained and have completed the present invention.

本発明は、上記の知見に基づきなされたものであって、上記課題を有利に解決することを目的とするものであり、本発明の一態様は、少なくとも培養面が脂環構造含有重合体で構成される培養容器に、ビトロネクチン濃度が0.50〜1.20μg/mlのコート剤を用いて、少なくとも前記培養面にコーティングを施し、該コーティングが施された前記培養容器内で人工多能性幹細胞を培養し、前記培養面に人工多能性幹細胞を接着させて内胚葉細胞へと分化誘導させる、人工多能性幹細胞の分化誘導方法である。
脂環構造含有重合体で構成される培養容器に対してビトロネクチン濃度が0.50〜1.20μg/mlのコート剤を用いることにより、人工多能性幹細胞を効率よく内胚葉細胞へと分化誘導することができる。
The present invention has been made on the basis of the above findings, and is intended to advantageously solve the above problems. One aspect of the present invention is that at least the culture surface is an alicyclic structure-containing polymer. A coating container having a vitronectin concentration of 0.50 to 1.20 μg / ml is applied to the configured culture container, and at least the culture surface is coated, and artificial pluripotency is applied in the culture container to which the coating is applied. It is a method for inducing differentiation of induced pluripotent stem cells, in which stem cells are cultured, and induced pluripotent stem cells are adhered to the culture surface to induce differentiation into endoderm cells.
Induction of differentiation of induced pluripotent stem cells into endoderm cells efficiently by using a coating agent having a vitronectin concentration of 0.50 to 1.20 μg / ml to a culture vessel composed of a polymer containing an alicyclic structure can do.

また、上記態様では、前記脂環構造含有重合体が、極性基を有しないものであることが好ましい。脂環構造含有重合体が極性基を有しない場合に、ビトロネクチンの濃度を制御することによるiPS細胞の接着性の調節が容易となるからである。   Moreover, in the said aspect, it is preferable that the said alicyclic structure containing polymer does not have a polar group. This is because, when the alicyclic structure-containing polymer does not have a polar group, it is easy to adjust the adhesion of iPS cells by controlling the concentration of vitronectin.

本発明によれば、人工多能性幹細胞を効率よく内胚葉細胞へと分化誘導することができる。   According to the present invention, induced pluripotent stem cells can be efficiently induced to differentiate into endoderm cells.

図1は、ビトロネクチン濃度が0.15〜5.00μg/mlのコート剤で、表面処理されたノルボルネン系単量体の開環重合体水素化物からなる培養容器上に、人工多能性幹細胞を播種した際の、顕微鏡観察像である。FIG. 1 shows that artificial pluripotent stem cells are placed on a culture vessel made of a ring-opening polymer hydride of norbornene monomer surface-treated with a coating agent having a vitronectin concentration of 0.15 to 5.00 μg / ml. It is a microscope observation image at the time of sowing. 図2は、ビトロネクチン濃度が0.50〜5.00μg/mlのコート剤で、表面処理されたノルボルネン系単量体の開環重合体水素化物からなる培養容器上に、人工多能性幹細胞を播種し、ACTIVIN AおよびBMP4で内胚葉細胞へと分化誘導した際の、内胚葉マーカー遺伝子の転写量を定量したものである。FIG. 2 shows that artificial pluripotent stem cells are placed on a culture vessel composed of a ring-opening polymer hydride of a norbornene monomer surface-treated with a coating agent having a vitronectin concentration of 0.50 to 5.00 μg / ml. The amount of transcription of the endoderm marker gene when seeded and induced to differentiate into endoderm cells with ACTIVINA A and BMP4 is quantified.

以下、本発明の実施形態について詳細に説明する。
本発明の方法は、人工多能性幹細胞を、中内胚葉細胞を経て内胚葉細胞へ分化させるにあたって、所定濃度のビトロネクチンを含むコート剤で、細胞や培地が接する面(以下、「培養面」という)を表面処理した脂環構造含有重合体で構成される培養容器を用いる点に特徴がある。
この表面処理を施すことで、人工多能性幹細胞が培養容器に接着することができ、かつ、脂環構造含有重合体との接触により得られる分化誘導効率の向上効果が得られる。上記方法によれば、人工多能性幹細胞を浮遊状態で培養しないため、三胚葉いずれにも分化可能な胚様体は形成されない。
Hereinafter, embodiments of the present invention will be described in detail.
In the method of the present invention, when an induced pluripotent stem cell is differentiated into an endoderm cell via a mesendoderm cell, a coating agent containing a predetermined concentration of vitronectin is used to contact a cell or a medium (hereinafter referred to as “culture surface” Is characterized by using a culture vessel composed of an alicyclic structure-containing polymer surface-treated.
By performing this surface treatment, the induced pluripotent stem cells can be adhered to the culture vessel, and the effect of improving differentiation induction efficiency obtained by contact with the alicyclic structure-containing polymer can be obtained. According to the above method, since the induced pluripotent stem cells are not cultured in a suspended state, an embryoid body that can differentiate into any of the three germ layers is not formed.

本明細書において、人工多能性幹細胞とは、体細胞に初期化因子を作用させることにより人工的に分化多能性を獲得した細胞を指す。   As used herein, an induced pluripotent stem cell refers to a cell that has artificially acquired differentiation pluripotency by causing a reprogramming factor to act on a somatic cell.

本明細書において、ビトロネクチンとは、ビトロネクチンレセプターを保有する細胞に対して接着活性を持つ478アミノ酸残基からなる糖タンパク質であり、動物細胞を培養する時に足場依存性細胞が培養面(専ら容器内側底面であるが、これに限定されない。)に接着し伸展して増殖を促すために用いられるものを指す。上記ビトロネクチンは、細胞接着分子として機能する範囲で、部分配列を欠失したものであってもよい。具体的には、N末端側にある20アミノ酸からなるシグナルドメインが欠失した組み換えビトロネクチン;C末端部分(399番目のアミノ酸〜478番目のアミノ酸配列部分)が欠失した組み換えビトロネクチン;その他市販されている組み換えビトロネクチン;が挙げられる。   In this specification, vitronectin is a glycoprotein consisting of 478 amino acid residues having adhesion activity to cells having a vitronectin receptor. When animal cells are cultured, anchorage-dependent cells are cultured on the culture surface (exclusively inside the container). It is the bottom surface, but is not limited to this.) It is used to adhere and extend to promote proliferation. The vitronectin may have a partial sequence deleted as long as it functions as a cell adhesion molecule. Specifically, recombinant vitronectin in which the signal domain consisting of 20 amino acids on the N-terminal side is deleted; recombinant vitronectin in which the C-terminal part (399th amino acid to 478th amino acid sequence part) is deleted; Recombinant vitronectin.

所定濃度のビトロネクチンを含むコート剤は、通常、リン酸緩衝生理食塩水(PBS)など体液の浸透圧と等しくpH緩衝性のある緩衝液に、上述したビトロネクチンを溶解させて調製される。緩衝液に溶解させるビトロネクチンの濃度は、0.50〜1.20μg/ml、好ましくは0.50〜1.00μg/ml、より好ましくは0.50μg/ml〜0.83μg/ml、特に好ましくは0.50μg/ml〜0.70μg/mlである。濃度が低すぎると、ビトロネクチンが培養面に十分にコートされず人工多能性幹細胞が接着せず、逆に高すぎると十分な分化誘導促進効果が得られなかったり、コーティングの操作性が悪くなったりする。   A coating agent containing a predetermined concentration of vitronectin is usually prepared by dissolving the aforementioned vitronectin in a buffer solution having a pH buffering property equal to the osmotic pressure of a body fluid such as phosphate buffered saline (PBS). The concentration of vitronectin dissolved in the buffer is 0.50 to 1.20 μg / ml, preferably 0.50 to 1.00 μg / ml, more preferably 0.50 μg / ml to 0.83 μg / ml, particularly preferably 0.50 μg / ml to 0.70 μg / ml. If the concentration is too low, vitronectin will not be sufficiently coated on the culture surface and artificial pluripotent stem cells will not adhere. On the other hand, if it is too high, sufficient differentiation induction promoting effect will not be obtained, and the coating operability will be poor. Or

上記コート剤を用いて脂環構造含有重合体からなる培養容器の培養面を表面処理することで、培養面にビトロネクチンをコーティングする。
培養面の表面処理方法は、一般的な細胞基質を培養容器にコートする方法と同様であり、通常、培養容器に上述のコート剤を入れて培養温度付近の温度で、通常10分間〜5時間、好ましくは30分間〜2時間静置しコート剤を培養面に接触させた後、コート剤を除去する方法が採用される。接触時間が短すぎるとビトロネクチンのコートが不十分となる。一方で、脂環構造含有重合体からなる成形体表面へのタンパク質吸着性は低く、ポリスチレンなどのように多層吸着しないため、接触時間を長くしても、吸着量が増えることはない。従って、接触時間を長くする必要はない。
The culture surface is coated with vitronectin by surface-treating the culture surface of the culture vessel made of the alicyclic structure-containing polymer using the coating agent.
The surface treatment method of the culture surface is the same as the method of coating a general cell substrate on a culture container. Usually, the above-mentioned coating agent is put in the culture container and the temperature is approximately 10 minutes to 5 hours at a temperature near the culture temperature. Preferably, a method of removing the coating agent after allowing it to stand for 30 minutes to 2 hours and bringing the coating agent into contact with the culture surface is employed. If the contact time is too short, the vitronectin coat will be insufficient. On the other hand, the protein adsorptivity to the surface of a molded body made of an alicyclic structure-containing polymer is low, and multilayer adsorption is not performed as in polystyrene, so that even if the contact time is increased, the amount of adsorption does not increase. Therefore, it is not necessary to lengthen the contact time.

なお、コート剤除去後、ビトロネクチンの乾燥を防ぐために、速やかに培地を添加することが望ましい。
培養容器に添加するコート剤の量は、脂環構造含有重合体で構成される培養容器の表面は水性溶液をはじきやすいため、一般的なポリスチレン製細胞培養容器に添加するコート剤量より1.5〜3倍程度多く添加することが望ましく、具体的には培養容器底面積1cmに対して、0.15〜0.25mlを添加するのが好ましい。
In addition, it is desirable to add a medium immediately after removing the coating agent in order to prevent drying of vitronectin.
The amount of the coating agent added to the culture vessel is 1. more than the amount of the coating agent added to a general polystyrene cell culture vessel because the surface of the culture vessel composed of the alicyclic structure-containing polymer easily repels the aqueous solution. It is desirable to add about 5 to 3 times more, specifically, 0.15 to 0.25 ml is preferably added to 1 cm 2 of the bottom area of the culture vessel.

本発明において、人工多能性幹細胞を内胚葉細胞へ分化誘導するためには、まず中内胚葉細胞への分化誘導が必要となる。中内胚葉細胞への分化誘導は、公知の中内胚葉細胞への分化誘導培地を用い、採用した分化誘導培地に適した培養条件で培養すればよい。その後、内胚葉細胞へ分化誘導するため、培地を、公知の内胚葉細胞への分化誘導培地に変更し、採用した分化誘導培地に適した培養条件で培養すれば良い。   In the present invention, in order to induce differentiation of induced pluripotent stem cells into endoderm cells, it is first necessary to induce differentiation into mesendoderm cells. Differentiation induction into mesendoderm cells may be performed using a known differentiation induction medium for mesendoderm cells and culture conditions suitable for the adopted differentiation induction medium. Thereafter, in order to induce differentiation into endoderm cells, the medium may be changed to a known differentiation induction medium for endoderm cells and cultured under culture conditions suitable for the adopted differentiation induction medium.

液体培地には、添加剤を配合することもできる。添加剤としては、ミネラル、金属、ビタミン成分等が挙げられる。
これらの添加剤は一種単独で、あるいは二種以上を組み合わせて用いることができる。
An additive can also be mix | blended with a liquid culture medium. Examples of additives include minerals, metals, and vitamin components.
These additives can be used alone or in combination of two or more.

本発明に用いる脂環構造含有重合体で構成される培養容器は、脂環構造含有重合体を培養容器として用いることが可能な任意の形状に成形してなるものである。培養容器のうち、少なくとも細胞や培養液と接する培養面が脂環構造含有重合体で構成されていればよい。あるいは、培養容器全体が脂環構造含有重合体からなることとしてもよい。例えば、バッグなどの場合、異なるポリマー材料からなるフィルムの積層体であって、最内層(バッグ内面)が脂環構造含有重合体からなるフィルムにより形成された層であればよい。また、培養ディッシュであれば、必要に応じて添加剤を加えて脂環構造含有重合体を成形し、実質的に容器全体を脂環構造含有重合体で構成することもできる。   The culture vessel composed of the alicyclic structure-containing polymer used in the present invention is formed by molding the alicyclic structure-containing polymer into an arbitrary shape that can be used as a culture vessel. Of the culture containers, at least the culture surface in contact with the cells and the culture solution may be composed of an alicyclic structure-containing polymer. Alternatively, the entire culture vessel may be made of an alicyclic structure-containing polymer. For example, in the case of a bag or the like, it may be a laminate of films made of different polymer materials, and the innermost layer (bag inner surface) may be a layer formed of a film made of an alicyclic structure-containing polymer. Moreover, if it is a culture dish, an additive may be added as needed and an alicyclic structure containing polymer may be shape | molded, and the whole container can also be comprised with an alicyclic structure containing polymer.

培養容器の成形方法は、培養容器の形状に応じて任意に選択することができる。成形方法の具体例としては、射出成形法、押出成形法、キャスト成形法、インフレーション成形法、ブロー成形法、真空成形法、プレス成形法、圧縮成形法、回転成形法、カレンダー成形法、圧延成形法、切削成形法、紡糸等が挙げられ、これらの成形法を組み合わせたり、成形後必要に応じて延伸等の後処理をすることもできる。   The method for forming the culture vessel can be arbitrarily selected according to the shape of the culture vessel. Specific examples of molding methods include injection molding, extrusion molding, cast molding, inflation molding, blow molding, vacuum molding, press molding, compression molding, rotational molding, calendar molding, rolling molding. Method, cutting molding method, spinning, and the like. These molding methods can be combined, or post-treatment such as stretching can be performed as necessary after molding.

脂環構造含有重合体は、主鎖および/または側鎖に脂環構造を有する樹脂であり、機械的強度、耐熱性などの観点から、主鎖に脂環構造を含有するものが好ましく、分化誘導効率の観点から、極性基を有しないものがより好ましい。ここで、極性基とは、極性のある原子団を指す。極性基としては、アミノ基、カルボキシル基、ヒドロキシル基、酸無水物基などが挙げられる。   The alicyclic structure-containing polymer is a resin having an alicyclic structure in the main chain and / or side chain, and preferably contains an alicyclic structure in the main chain from the viewpoint of mechanical strength, heat resistance, etc. From the viewpoint of induction efficiency, those having no polar group are more preferable. Here, the polar group refers to a polar atomic group. Examples of the polar group include an amino group, a carboxyl group, a hydroxyl group, and an acid anhydride group.

上記脂環構造としては、飽和環状炭化水素(シクロアルカン)構造、不飽和環状炭化水素(シクロアルケン)構造などが挙げられるが、機械的強度、耐熱性などの観点から、シクロアルカン構造やシクロアルケン構造が好ましく、中でもシクロアルカン構造を有するものが最も好ましい。   Examples of the alicyclic structure include a saturated cyclic hydrocarbon (cycloalkane) structure and an unsaturated cyclic hydrocarbon (cycloalkene) structure. From the viewpoint of mechanical strength and heat resistance, the cycloalkane structure and the cycloalkene structure are exemplified. A structure is preferable, and a structure having a cycloalkane structure is most preferable.

脂環構造を構成する炭素原子数は、格別な制限はないが、通常4〜30個、好ましくは5〜20個、より好ましくは5〜15個である。脂環構造を構成する炭素原子数がこの範囲内であるときに、機械的強度、耐熱性、および成形性の特性が高度にバランスされ、好適である。   The number of carbon atoms constituting the alicyclic structure is not particularly limited, but is usually 4 to 30, preferably 5 to 20, and more preferably 5 to 15. When the number of carbon atoms constituting the alicyclic structure is within this range, the mechanical strength, heat resistance, and moldability characteristics are highly balanced, which is preferable.

脂環構造含有重合体中の脂環構造を有する繰り返し単位の割合は、使用目的に応じて適宜選択されればよいが、通常30重量%以上、好ましくは50重量%以上、より好ましくは70重量%以上である。脂環構造含有重合体中の脂環構造を有する繰り返し単位の割合が過度に少ないと耐熱性に劣り好ましくない。脂環構造含有重合体中の脂環構造を有する繰り返し単位以外の残部は、格別な限定はなく、使用目的に応じて適宜選択される。   The proportion of the repeating unit having an alicyclic structure in the alicyclic structure-containing polymer may be appropriately selected according to the purpose of use, but is usually 30% by weight or more, preferably 50% by weight or more, more preferably 70% by weight. % Or more. If the proportion of the repeating unit having an alicyclic structure in the alicyclic structure-containing polymer is excessively small, the heat resistance is inferior, which is not preferable. The remainder other than the repeating unit having an alicyclic structure in the alicyclic structure-containing polymer is not particularly limited and is appropriately selected according to the purpose of use.

脂環構造含有重合体の具体例としては、(1)ノルボルネン系重合体、(2)単環の環状オレフィン系重合体、(3)環状共役ジエン系重合体、(4)ビニル脂環式炭化水素系重合体、および(1)〜(4)の水素化物などが挙げられる。これらの中でも、耐熱性、機械的強度等の観点から、ノルボルネン系重合体およびその水素化物が好ましい。   Specific examples of the alicyclic structure-containing polymer include (1) norbornene polymer, (2) monocyclic olefin polymer, (3) cyclic conjugated diene polymer, and (4) vinyl alicyclic carbonization. Examples thereof include hydrogen polymers and hydrides of (1) to (4). Among these, norbornene-based polymers and hydrides thereof are preferable from the viewpoints of heat resistance, mechanical strength, and the like.

(1)ノルボルネン系重合体
ノルボルネン系重合体は、ノルボルネン骨格を有する単量体であるノルボルネン系単量体を重合してなるものであり、開環重合によって得られるものと、付加重合によって得られるものに大別される。
(1) Norbornene-based polymer The norbornene-based polymer is obtained by polymerizing a norbornene-based monomer that is a monomer having a norbornene skeleton, and is obtained by ring-opening polymerization or by addition polymerization. Broadly divided into things.

開環重合によって得られるものとしては、ノルボルネン系単量体の開環重合体およびノルボルネン系単量体とこれと開環共重合可能なその他の単量体との開環重合体、ならびにこれらの水素化物などが挙げられる。付加重合によって得られるものとしては、ノルボルネン系単量体の付加重合体およびノルボルネン系単量体とこれと共重合可能なその他の単量体との付加重合体などが挙げられる。これらの中でも、ノルボルネン系単量体の開環重合体水素化物が、耐熱性、機械的強度等の観点から好ましい。   Examples of the ring-opening polymer obtained by ring-opening polymerization include ring-opening polymers of norbornene monomers, ring-opening polymers of norbornene monomers and other monomers capable of ring-opening copolymerization, and these A hydride etc. are mentioned. Examples of those obtained by addition polymerization include addition polymers of norbornene monomers and addition polymers of norbornene monomers and other monomers copolymerizable therewith. Among these, a ring-opening polymer hydride of a norbornene-based monomer is preferable from the viewpoint of heat resistance, mechanical strength, and the like.

ノルボルネン系重合体の合成に使用可能なノルボルネン系単量体としては、ビシクロ[2.2.1]ヘプタ−2−エン(慣用名ノルボルネン)、5−メチル−ビシクロ[2.2.1]ヘプタ−2−エン、5,5−ジメチル−ビシクロ[2.2.1]ヘプタ−2−エン、5−エチル−ビシクロ[2.2.1]ヘプタ−2−エン、5−エチリデン−ビシクロ[2.2.1]ヘプタ−2−エン、5−ビニル−ビシクロ[2.2.1]ヘプタ−2−エン、5−プロペニルビシクロ[2.2.1]ヘプタ−2−エン、5−メトキシカルボニル−ビシクロ[2.2.1]ヘプタ−2−エン、5−シアノビシクロ[2.2.1]ヘプタ−2−エン、5−メチル−5−メトキシカルボニル−ビシクロ[2.2.1]ヘプタ−2−エン等の2環式単量体;
トリシクロ[4.3.01,6.12,5]デカ−3,7−ジエン(慣用名ジシクロペンタジエン)、2−メチルジシクロペンタジエン、2,3−ジメチルジシクロペンタジエン、2,3−ジヒドロキシジシクロペンタジエン等の3環式単量体;
テトラシクロ[4.4.0.12,5.17,10]−3−ドデセン(テトラシクロドデセン)、テトラシクロ[4.4.0.12,5.17,10]−3−ドデセン、8−メチルテトラシクロ[4.4.0.12,5.17,10]−3−ドデセン、8−エチルテトラシクロ[4.4.0.12,5.17,10]−3−ドデセン、8−エチリデンテトラシクロ[4.4.0.12,5.17,10]−3−ドデセン、8,9−ジメチルテトラシクロ[4.4.0.12,5.17,10]−3−ドデセン、8−エチル−9−メチルテトラシクロ[4.4.0.12,5.17,10]−3−ドデセン、8−エチリデン−9−メチルテトラシクロ[4.4.0.12,5.17,10]−3−ドデセン、8−メチル−8−カルボキシメチルテトラシクロ[4.4.0.12,5.17,10]−3−ドデセン、
7,8−ベンゾトリシクロ[4.3.0.12,5]デカ−3−エン(慣用名メタノテトラヒドロフルオレン:1,4−メタノ−1,4,4a,9a−テトラヒドロフルオレンともいう)、1,4−メタノ−8−メチル−1,4,4a,9a−テトラヒドロフルオレン、1,4−メタノ−8−クロロ−1,4,4a,9a−テトラヒドロフルオレン、1,4−メタノ−8−ブロモ−1,4,4a,9a−テトラヒドロフルオレン等の4環式単量体;等が挙げられる。
Examples of norbornene monomers that can be used for the synthesis of norbornene polymers include bicyclo [2.2.1] hept-2-ene (commonly used norbornene) and 5-methyl-bicyclo [2.2.1] hepta. 2-ene, 5,5-dimethyl-bicyclo [2.2.1] hept-2-ene, 5-ethyl-bicyclo [2.2.1] hept-2-ene, 5-ethylidene-bicyclo [2 2.1] hept-2-ene, 5-vinyl-bicyclo [2.2.1] hept-2-ene, 5-propenylbicyclo [2.2.1] hept-2-ene, 5-methoxycarbonyl -Bicyclo [2.2.1] hept-2-ene, 5-cyanobicyclo [2.2.1] hept-2-ene, 5-methyl-5-methoxycarbonyl-bicyclo [2.2.1] hepta Bicyclic monomers such as 2-ene;
Tricyclo [4.3.0 1,6 . 1 2,5 ] deca-3,7-diene (common name dicyclopentadiene), 2-methyldicyclopentadiene, 2,3-dimethyldicyclopentadiene, 2,3-dihydroxydicyclopentadiene, etc. Mer;
Tetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene (tetracyclododecene), tetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-methyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-ethyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-ethylidenetetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8,9-dimethyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-ethyl-9-methyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-ethylidene-9-methyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-methyl-8-carboxymethyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene,
7,8-benzotricyclo [4.3.0.1 2,5 ] dec-3-ene (common name methanotetrahydrofluorene: also called 1,4-methano-1,4,4a, 9a-tetrahydrofluorene) 1,4-methano-8-methyl-1,4,4a, 9a-tetrahydrofluorene, 1,4-methano-8-chloro-1,4,4a, 9a-tetrahydrofluorene, 1,4-methano-8 -Tetracyclic monomers such as bromo-1,4,4a, 9a-tetrahydrofluorene;

ノルボルネン系単量体と開環共重合可能なその他の単量体としては、シクロヘキセン、シクロヘプテン、シクロオクテン、1,4−シクロヘキサジエン、1,5−シクロオクタジエン、1,5−シクロデカジエン、1,5,9−シクロドデカトリエン、1,5,9,13−シクロヘキサデカテトラエン等の単環のシクロオレフィン系単量体が挙げられる。
これらの単量体は、置換基を1種または2種以上有していてもよい。置換基としては、アルキル基、アルキレン基、アリール基、シリル基、アルコキシカルボニル基、アルキリデン基等が挙げられる。
Other monomers capable of ring-opening copolymerization with norbornene monomers include cyclohexene, cycloheptene, cyclooctene, 1,4-cyclohexadiene, 1,5-cyclooctadiene, 1,5-cyclodecadiene, And monocyclic cycloolefin monomers such as 1,5,9-cyclododecatriene and 1,5,9,13-cyclohexadecatetraene.
These monomers may have one or more substituents. Examples of the substituent include an alkyl group, an alkylene group, an aryl group, a silyl group, an alkoxycarbonyl group, and an alkylidene group.

ノルボルネン系単量体と付加共重合可能なその他の単量体としては、エチレン、プロピレン、1−ブテン、1−ペンテン、1−ヘキセン等の炭素数2〜20のα−オレフィン系単量体;シクロブテン、シクロペンテン、シクロヘキセン、シクロオクテン、テトラシクロ[9.2.1.02,10.03,8]テトラデカ−3,5,7,12−テトラエン(3a,5,6,7a−テトラヒドロ−4,7−メタノ−1H−インデンとも言う)等のシクロオレフィン系単量体;1,4−ヘキサジエン、4−メチル−1,4−ヘキサジエン、5−メチル−1,4−ヘキサジエン、1,7−オクタジエン等の非共役ジエン系単量体;等が挙げられる。 Other monomers capable of addition copolymerization with a norbornene monomer include α-olefin monomers having 2 to 20 carbon atoms such as ethylene, propylene, 1-butene, 1-pentene and 1-hexene; cyclobutene, cyclopentene, cyclohexene, cyclooctene, tetracyclo [9.2.1.0 2,10. Cycloolefin monomers such as 0 3,8 ] tetradeca-3,5,7,12-tetraene (also referred to as 3a, 5,6,7a-tetrahydro-4,7-methano-1H-indene); And non-conjugated diene monomers such as 4-hexadiene, 4-methyl-1,4-hexadiene, 5-methyl-1,4-hexadiene, and 1,7-octadiene.

これらの中でも、ノルボルネン系単量体と付加共重合可能なその他の単量体としては、α−オレフィン系単量体が好ましく、エチレンがより好ましい。
これらの単量体は、置換基を1種または2種以上有していてもよい。置換基としては、アルキル基、アルキレン基、アリール基、シリル基、アルコキシカルボニル基、アルキリデン基等が挙げられる。
Among these, as other monomers that can be addition copolymerized with norbornene monomers, α-olefin monomers are preferable, and ethylene is more preferable.
These monomers may have one or more substituents. Examples of the substituent include an alkyl group, an alkylene group, an aryl group, a silyl group, an alkoxycarbonyl group, and an alkylidene group.

ノルボルネン系単量体の開環重合体、またはノルボルネン系単量体とこれと開環共重合可能なその他の単量体との開環重合体は、単量体成分を、公知の開環重合触媒の存在下で重合して得ることができる。開環重合触媒としては、例えば、ルテニウム、オスミウムなどの金属のハロゲン化物と、硝酸塩またはアセチルアセトン化合物、および還元剤とからなる触媒、あるいは、チタン、ジルコニウム、タングステン、モリブデンなどの金属のハロゲン化物またはアセチルアセトン化合物と、有機アルミニウム化合物とからなる触媒を用いることができる。
ノルボルネン系単量体の開環重合体水素化物は、通常、上記開環重合体の重合溶液に、ニッケル、パラジウムなどの遷移金属を含む公知の水素化触媒を添加し、炭素−炭素不飽和結合を水素化することにより得ることができる。
A ring-opening polymer of a norbornene-based monomer, or a ring-opening polymer of a norbornene-based monomer and another monomer capable of ring-opening copolymerization with a monomer component is a known ring-opening polymerization. It can be obtained by polymerization in the presence of a catalyst. Examples of the ring-opening polymerization catalyst include a catalyst comprising a metal halide such as ruthenium or osmium, a nitrate or an acetylacetone compound, and a reducing agent, or a metal halide or acetylacetone such as titanium, zirconium, tungsten or molybdenum. A catalyst comprising a compound and an organoaluminum compound can be used.
The ring-opening polymer hydride of a norbornene-based monomer is usually obtained by adding a known hydrogenation catalyst containing a transition metal such as nickel or palladium to the polymerization solution of the above-described ring-opening polymer, and then adding a carbon-carbon unsaturated bond. Can be obtained by hydrogenation.

ノルボルネン系単量体の付加重合体、またはノルボルネン系単量体とこれと共重合可能なその他の単量体との付加重合体は、単量体成分を、公知の付加重合触媒の存在下で重合して得ることができる。付加重合触媒としては、例えば、チタン、ジルコニウムまたはバナジウム化合物と有機アルミニウム化合物とからなる触媒を用いることができる。   An addition polymer of a norbornene-based monomer or an addition polymer of a norbornene-based monomer and another monomer copolymerizable therewith is a monomer component in the presence of a known addition polymerization catalyst. It can be obtained by polymerization. As the addition polymerization catalyst, for example, a catalyst composed of a titanium, zirconium or vanadium compound and an organoaluminum compound can be used.

(2)単環の環状オレフィン系重合体
単環の環状オレフィン系重合体としては、例えば、シクロヘキセン、シクロヘプテン、シクロオクテンなどの、単環の環状オレフィン系単量体の付加重合体を用いることができる。
(3)環状共役ジエン系重合体
環状共役ジエン系重合体としては、例えば、シクロペンタジエン、シクロヘキサジエンなどの環状共役ジエン系単量体を1,2−または1,4−付加重合した重合体およびその水素化物などを用いることができる。
(4)ビニル脂環式炭化水素重合体
ビニル脂環式炭化水素重合体としては、例えば、ビニルシクロヘキセン、ビニルシクロヘキサンなどのビニル脂環式炭化水素系単量体の重合体およびその水素化物;スチレン、α−メチルスチレンなどのビニル芳香族系単量体の重合体の芳香環部分の水素化物;などが挙げられる。ビニル脂環式炭化水素重合体は、これらの単量体と共重合可能な他の単量体との共重合体であってもよい。
(2) Monocyclic cyclic olefin polymer As the monocyclic olefin polymer, for example, an addition polymer of a monocyclic olefin monomer such as cyclohexene, cycloheptene, or cyclooctene can be used. it can.
(3) Cyclic conjugated diene polymer As the cyclic conjugated diene polymer, for example, a polymer obtained by subjecting a cyclic conjugated diene monomer such as cyclopentadiene or cyclohexadiene to 1,2- or 1,4-addition polymerization, and The hydride can be used.
(4) Vinyl alicyclic hydrocarbon polymer Examples of the vinyl alicyclic hydrocarbon polymer include polymers of vinyl alicyclic hydrocarbon monomers such as vinylcyclohexene and vinylcyclohexane, and hydrogenated products thereof; styrene; , Hydrides of aromatic ring portions of polymers of vinyl aromatic monomers such as α-methylstyrene; and the like. The vinyl alicyclic hydrocarbon polymer may be a copolymer with other monomers copolymerizable with these monomers.

脂環構造含有重合体の分子量に格別な制限はないが、シクロヘキサン溶液(重合体が溶解しない場合はトルエン溶液)のゲル・パーミエーション・クロマトグラフィーで測定したポリイソプレン換算の重量平均分子量で、通常5,000以上であり、好ましくは5,000〜500,000、より好ましくは8,000〜200,000、特に好ましくは10,000〜100,000である。重量平均分子量がこの範囲内であるときに、機械的強度と成形加工性とが高度にバランスし、好適である。   The molecular weight of the alicyclic structure-containing polymer is not particularly limited, but is usually a polyisoprene equivalent weight average molecular weight measured by gel permeation chromatography of a cyclohexane solution (or a toluene solution if the polymer does not dissolve). It is 5,000 or more, preferably 5,000 to 500,000, more preferably 8,000 to 200,000, and particularly preferably 10,000 to 100,000. When the weight average molecular weight is within this range, the mechanical strength and the moldability are highly balanced, which is preferable.

脂環構造含有重合体のガラス転移温度は、使用目的に応じて適宜選択されればよいが、通常50〜300℃、好ましくは100〜280℃、特に好ましくは100〜250℃、さらに好ましくは100〜200℃である。ガラス転移温度がこの範囲内であるときに、耐熱性と成形加工性とが高度にバランスし、好適である。
本発明において脂環構造含有重合体のガラス転移温度は、JIS K 7121に基づいて測定されたものである。
The glass transition temperature of the alicyclic structure-containing polymer may be appropriately selected depending on the purpose of use, but is usually 50 to 300 ° C, preferably 100 to 280 ° C, particularly preferably 100 to 250 ° C, and more preferably 100. ~ 200 ° C. When the glass transition temperature is within this range, heat resistance and molding processability are highly balanced and suitable.
In the present invention, the glass transition temperature of the alicyclic structure-containing polymer is measured based on JIS K7121.

上記脂環構造含有重合体は、それぞれ単独で、あるいは2種以上を組み合わせて用いることができる。
また、脂環構造含有重合体には、熱可塑性樹脂材料で通常用いられている配合剤、例えば、軟質重合体、酸化防止剤、紫外線吸収剤、光安定剤、近赤外線吸収剤、離型剤、染料や顔料などの着色剤、可塑剤、帯電防止剤、蛍光増白剤などの配合剤を、通常採用される量、添加することができる。
また、脂環構造含有重合体には、軟質重合体以外のその他の重合体(以下、単に「その他の重合体」という)を混合しても良い。脂環構造含有重合体に混合されるその他の重合体の量は、脂環構造含有重合体100質量部に対して、通常200質量部以下、好ましくは150質量部以下、より好ましくは100質量部以下である。
脂環構造含有重合体に対して配合する各種配合剤やその他の重合体の割合が多すぎると細胞が浮遊し難くなるため、いずれも脂環構造含有重合体の性質を損なわない範囲で配合することが好ましい。
脂環構造含有重合体と配合剤やその他の重合体との混合方法は、ポリマー中に配合剤が十分に分散する方法であれば、特に限定されない。また、配合の順番に格別な制限はない。配合方法としては、例えば、ミキサー、一軸混練機、二軸混練機、ロール、ブラベンダー、押出機などを用いて樹脂を溶融状態で混練する方法、適当な溶剤に溶解して分散させた後、凝固法、キャスト法、または直接乾燥法により溶剤を除去する方法などが挙げられる。
二軸混練機を用いる場合、混練後は、通常は溶融状態で棒状に押出し、ストランドカッターで適当な長さに切り、ペレット化して用いられることが多い。
The said alicyclic structure containing polymer can be used individually or in combination of 2 or more types, respectively.
In addition, for the alicyclic structure-containing polymer, a compounding agent usually used in thermoplastic resin materials, for example, a soft polymer, an antioxidant, an ultraviolet absorber, a light stabilizer, a near infrared absorber, a release agent. Additives such as colorants such as dyes and pigments, plasticizers, antistatic agents, fluorescent brighteners, and the like can be added in amounts that are usually employed.
In addition, the alicyclic structure-containing polymer may be mixed with another polymer other than the soft polymer (hereinafter simply referred to as “other polymer”). The amount of the other polymer mixed with the alicyclic structure-containing polymer is usually 200 parts by mass or less, preferably 150 parts by mass or less, more preferably 100 parts by mass with respect to 100 parts by mass of the alicyclic structure-containing polymer. It is as follows.
If the proportion of various compounding agents and other polymers to be blended with the alicyclic structure-containing polymer is too high, cells will not float easily, so all are blended within the range that does not impair the properties of the alicyclic structure-containing polymer. It is preferable.
The mixing method of the alicyclic structure-containing polymer and the compounding agent or other polymer is not particularly limited as long as the compounding agent is sufficiently dispersed in the polymer. Moreover, there is no special restriction | limiting in the order of a mixing | blending. As a blending method, for example, a method of kneading a resin in a molten state using a mixer, a uniaxial kneader, a biaxial kneader, a roll, a Brabender, an extruder, etc., after dissolving and dispersing in a suitable solvent, Examples thereof include a method of removing the solvent by a coagulation method, a casting method, or a direct drying method.
When a biaxial kneader is used, after kneading, it is usually extruded in a rod shape in a molten state, cut into an appropriate length with a strand cutter, and pelletized in many cases.

脂環構造含有重合体で構成される容器の成形方法は、所望される培養容器の形状に応じて任意に選択することができる。成形方法としては、例えば、射出成形法、押出成形法、キャスト成形法、インフレーション成形法、ブロー成形法、真空成形法、プレス成形法、圧縮成形法、回転成形法、カレンダー成形法、圧延成形法、切削成形法、紡糸等が挙げられ、これらの成形法を組み合わせたり、成形後必要に応じて延伸等の後処理をすることもできる。
培養容器の形状としては、ディッシュ、プレート、マイクロ流路チップ、バッグ、チューブ、スキャホールド、カップ、ジャー・ファーメンターなどが挙げられる。
The molding method of the container composed of the alicyclic structure-containing polymer can be arbitrarily selected according to the desired shape of the culture container. Examples of molding methods include injection molding, extrusion molding, cast molding, inflation molding, blow molding, vacuum molding, press molding, compression molding, rotational molding, calendar molding, and rolling molding. , Cutting molding method, spinning and the like, and these molding methods can be combined, or post-treatment such as stretching can be carried out as necessary after molding.
Examples of the shape of the culture container include a dish, a plate, a microchannel chip, a bag, a tube, a scaffold, a cup, and a jar fermenter.

本発明において培養容器は、滅菌処理することが好ましい。
滅菌処理の方法に格別な制限はなく、高圧蒸気法や乾熱法などの加熱法;γ線や電子線などの放射線を照射する放射線法や高周波を照射する照射法;酸化エチレンガス(EOG)などのガスを接触させるガス法;滅菌フィルタを用いる濾過法;など、医療分野で一般的に採用される方法から、成形体の形状や用いる細胞に応じて、選択することができる。なかでも、表面の極性状態の変化が少ないことから、ガス法が好ましい。
In the present invention, the culture container is preferably sterilized.
There are no particular restrictions on the method of sterilization, heating methods such as the high-pressure steam method and dry heat method; radiation methods that irradiate radiation such as γ rays and electron beams; irradiation methods that irradiate high frequencies; ethylene oxide gas (EOG) The method can be selected from methods generally employed in the medical field, such as a gas method in which a gas is brought into contact; a filtration method using a sterilizing filter; Among these, the gas method is preferable because the change in the polar state of the surface is small.

また、培養面を含む培養容器の内表面は、プラズマ処理、コロナ放電処理、オゾン処理、紫外線照射処理など培養容器に対して一般的に施す、滅菌目的以外の処理を行うこともできる。ただし、これらの表面処理操作を施すことにより発生する費用を抑えることができることや、表面処理に伴う培養容器内表面の部分分解により清浄性が損なわれるおそれがあることなどから、これらの内表面処理操作を行わない、または内表面処理前の容器底面(培養液に接する側)の水接触角に対して、使用時の同底面の水接触角が±20%、好ましくは±10%の弱い表面処理しかされていないことが好ましい。ここで、水接触角は、全自動接触角計(協和界面科学社製「LCD−400S」)を用い、ディッシュ底面をΦ30mmのサークルカッターで切り取って試料の中心と、そこを中央とする1辺20mmの正方形の頂点4か所の計5か所を測定点とし、液滴の半径rと高さhを求め、tanθ1=h/r,θ=2θ→θ=2arctan(h/r)で求められるθである(θ/2法)。 In addition, the inner surface of the culture vessel including the culture surface can be subjected to treatments other than the sterilization purpose generally applied to the culture vessel such as plasma treatment, corona discharge treatment, ozone treatment, and ultraviolet irradiation treatment. However, these inner surface treatments are possible because the costs generated by performing these surface treatment operations can be reduced, and the cleanliness may be impaired by partial decomposition of the inner surface of the culture vessel accompanying the surface treatment. Weak surface with water contact angle of ± 20%, preferably ± 10% of the bottom surface of the container when not used or with respect to the water contact angle of the bottom surface of the container (the side in contact with the culture solution) before the inner surface treatment It is preferred that it has only been treated. Here, the water contact angle is determined by using a fully automatic contact angle meter (“LCD-400S” manufactured by Kyowa Interface Science Co., Ltd.), cutting the bottom of the dish with a Φ30 mm circle cutter, and the center of the sample. Using a total of 5 points of 4 apexes of a 20 mm square as the measurement points, the radius r and height h of the droplet are obtained, and tan θ1 = h / r, θ = 2θ 1 → θ = 2 arctan (h / r) The required θ (θ / 2 method).

以下、実施例を挙げて本発明を具体的に説明するが、本発明はこれらの実施例に限定されるものではない。   EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated concretely, this invention is not limited to these Examples.

(実施例I)
脂環構造含有重合体として、ゼオノア(登録商標)1060R(日本ゼオン社製、ノルボルネン系単量体の開環重合体水素化物;以下、単に「1060R」という)を用いて、射出形成法により、直径35mmのウェルを6つもつ、6ウェルプレートを得、次いで、エチレンオキサイド滅菌処理を行った。以下、この培養容器を「1060R製プレート」という。
培養容器として1060R製プレートに、ビトロネクチン(Life Technologies社製A147000)を表1に記載の濃度になるようにリン酸緩衝液(PBS)に溶解して希釈したコート剤を2ml入れ、37℃で1時間温置した後、コート剤を容器から除去し、ビトロネクチンコートしたプレートを得た。
通常、ビトロネクチンをコート剤として使用する場合、5.0μg/mlでの使用が推奨されているので、その濃度を基準値(1倍)として、希釈列を作製し、各々コート剤として用いた。
得られたプレートの各ウェルに、基礎培地として3%血清代替品KnockOut(登録商標) Serum Replacement(以下、「KSR」という;Thermofisher Scientific社製)、ACTIVIN A(R&D社製、最終濃度:15ug/mL)、BMP4(R&D社製、最終濃度:3.75ng/mL)を、基礎培地(コージンバイオ社製)に添加し、合成培地(以下「iPS分化誘導培地」という)を作製し、1060R製プレートの各ウェルに入れた。次いで、人工多能性幹細胞を3.3×10cells/ウェルで、1060R製プレートの各ウェルに播種した後、ROCK阻害剤(Wako社製、最終濃度:10μM)を添加し、5%CO雰囲気下37℃で24時間培養した。その後、培地を除去し、再び、iPS分化誘導培養培地を入れて、2日間、同じ条件下で培養を継続した。培地交換は24時間毎に実施した。培養中の細胞の顕微鏡観察像を図1に示す。
コート剤のビトロネクチン濃度を、0.60μg/mlとした場合に、接着細胞数のわずかな減少が確認されたものの、ビトロネクチン濃度:0.60μg/ml以上では分化誘導試験に供するに問題ない程度に十分な接着状態を保っていた。ビトロネクチン濃度を、0.50μg/mlまで下げた場合であっても、細胞の接着状態は保たれる。一方、ビトロネクチン濃度:0.30μg/mlおよび0.15μg/mlでは、細胞は十分に接着状態を保てず、浮遊してしまう細胞(丸くなっている部分)も見られ、分化誘導試験を実施することが困難であった。
また、これら細胞試料から、中内胚葉マーカーであるCER1遺伝子の転写量を、リアルタイムPCR法(内部標準遺伝子は、GAPDH遺伝子)により定量したところ、0.60μg/ml以上のビトロネクチン濃度でコートしたプレートで培養した細胞試料では、いずれも、上記中内胚葉マーカーが発現されていた。
なお、ポリスチレン製6ウェルプレートを用いて同様の細胞培養を行ったところ、1060R製プレートと比較して接着細胞数に差が生じず、1060R製プレートにおいて十分に細胞の接着性が保たれていることを確認した。
Example I
As an alicyclic structure-containing polymer, using ZEONOR (registered trademark) 1060R (manufactured by Nippon Zeon Co., Ltd., a ring-opening polymer hydride of a norbornene monomer; hereinafter simply referred to as “1060R”), an injection molding method is used. A 6-well plate having 6 wells with a diameter of 35 mm was obtained, and then sterilized with ethylene oxide. Hereinafter, this culture container is referred to as “1060R plate”.
As a culture vessel, 2 ml of a coating agent obtained by dissolving vitronectin (Life Technologies A147000) dissolved in a phosphate buffer solution (PBS) so as to have the concentration shown in Table 1 was added to a 1060R plate as a culture container. After incubation for a period of time, the coating agent was removed from the container to obtain a vitronectin-coated plate.
Usually, when vitronectin is used as a coating agent, it is recommended to use 5.0 μg / ml. Therefore, a dilution column was prepared with the concentration as a reference value (1 time), and each was used as a coating agent.
In each well of the obtained plate, 3% serum replacement KnockOut (registered trademark) Serum Replacement (hereinafter referred to as “KSR”; Thermofisher Scientific, Inc.), ACTIVIN A (R & D, final concentration: 15 ug / mL) and BMP4 (manufactured by R & D, final concentration: 3.75 ng / mL) are added to a basal medium (manufactured by Kojin Bio) to produce a synthetic medium (hereinafter referred to as “iPS differentiation-inducing medium”), manufactured by 1060R Placed in each well of the plate. Next, after seeding the artificial pluripotent stem cells at 3.3 × 10 5 cells / well in each well of the 1060R plate, a ROCK inhibitor (manufactured by Wako, final concentration: 10 μM) was added, and 5% CO 2 was added. The cells were cultured at 37 ° C. for 24 hours under two atmospheres. Thereafter, the medium was removed, and the iPS differentiation-inducing culture medium was added again, and the culture was continued for 2 days under the same conditions. Medium change was performed every 24 hours. The microscope observation image of the cell in culture is shown in FIG.
When the vitronectin concentration of the coating agent was 0.60 μg / ml, a slight decrease in the number of adherent cells was confirmed, but when the vitronectin concentration was 0.60 μg / ml or more, there was no problem in providing a differentiation induction test. Sufficient adhesion was maintained. Even when the vitronectin concentration is lowered to 0.50 μg / ml, the cell adhesion state is maintained. On the other hand, at vitronectin concentrations: 0.30 μg / ml and 0.15 μg / ml, cells did not maintain sufficient adhesion, and some floating cells (rounded portions) were also observed. It was difficult to do.
Further, from these cell samples, the amount of transcription of the CER1 gene, which is a mesendoderm marker, was quantified by a real-time PCR method (internal standard gene is GAPDH gene), and a plate coated with a vitronectin concentration of 0.60 μg / ml or more. In all the cell samples cultured in the above, the above-mentioned mesendoderm marker was expressed.
In addition, when the same cell culture was performed using a 6-well plate made of polystyrene, there was no difference in the number of adherent cells compared to the 1060R-made plate, and the cell adhesion was sufficiently maintained in the 1060R-made plate. It was confirmed.

(実施例II)
1060R製プレートに用いるコート剤の濃度を表2の量に変更したこと以外は、実施例Iと同様に人工多能性幹細胞の培養を行った。
その後、上述のiPS分化誘導培地からBMP4のみを除去した内胚葉細胞分化用培地に交換して、5%CO雰囲気下37℃で更に2日間培養し、内胚葉細胞へ分化誘導を行った。
次いで、内胚葉マーカーであるSOX17遺伝子の転写量を、リアルタイムPCR法(内部標準遺伝子は、GAPDH遺伝子)により定量した。
比較対照として、培養容器を、市販のポリスチレン製6ウェルプレート(FALCON社製)に変えたこと以外は上述と同様にして、コート剤で表面処理した容器を作製し、上述と同様の細胞培養および分化誘導操作を行い、培養細胞の中内胚葉マーカーの発現を確認した後、内胚葉マーカーの発現を定量した。
ポリスチレン製6ウェルプレートに実施例Iと同様にしてビトロネクチン濃度5.00μg/mlのコート剤を塗布して実施例Iと同様にして定量された内胚葉マーカー量を1としたときの、各プレートでの内胚葉マーカー量の相対量を図2に示す。図2中、「TCPS」は、ポリスチレン製6ウェルプレートを意味し、「COP」は、1060R製プレートを意味する。
図2に示されるように、ビトロネクチン濃度1.20μg/ml、ビトロネクチン濃度0.80μg/ml、ビトロネクチン濃度0.50μg/mlで、細胞あたりの内胚葉マーカー量が増加した。
Example II
The induced pluripotent stem cells were cultured in the same manner as in Example I except that the concentration of the coating agent used in the 1060R plate was changed to the amount shown in Table 2.
Thereafter, the medium was replaced with an endoderm cell differentiation medium from which only BMP4 was removed from the above-mentioned iPS differentiation induction medium, and further cultured at 37 ° C. in a 5% CO 2 atmosphere to induce differentiation into endoderm cells.
Next, the amount of transcription of the SOX17 gene, which is an endoderm marker, was quantified by a real-time PCR method (internal standard gene is GAPDH gene).
As a comparative control, a vessel surface-treated with a coating agent was prepared in the same manner as described above except that the culture vessel was changed to a commercially available polystyrene 6-well plate (manufactured by FALCON). After performing differentiation induction operation and confirming the expression of the mesendoderm marker of cultured cells, the expression of the endoderm marker was quantified.
Each plate when a coating agent having a vitronectin concentration of 5.00 μg / ml was applied to a polystyrene 6-well plate in the same manner as in Example I and the amount of endoderm marker quantified in the same manner as in Example I was 1. FIG. 2 shows the relative amount of the endoderm marker amount. In FIG. 2, “TCPS” means a polystyrene 6-well plate, and “COP” means a 1060R plate.
As shown in FIG. 2, the amount of endoderm marker per cell increased at a vitronectin concentration of 1.20 μg / ml, a vitronectin concentration of 0.80 μg / ml, and a vitronectin concentration of 0.50 μg / ml.

図1および図2の結果から、ビトロネクチン濃度が0.50〜1.20μg/mlの範囲であるコート剤を用いると、細胞の接着能を保持しつつ、内胚葉分化誘導が促進されること示された。   From the results of FIGS. 1 and 2, it is shown that, when a coating agent having a vitronectin concentration in the range of 0.50 to 1.20 μg / ml is used, the induction of endoderm differentiation is promoted while maintaining the cell adhesion ability. It was done.

本発明の人工多能性幹細胞の分化誘導方法によれば、人工多能性幹細胞を効率よく内胚葉細胞へと分化誘導することができる。   According to the induced differentiation method of induced pluripotent stem cells of the present invention, induced induced pluripotent stem cells can be efficiently induced to differentiate into endoderm cells.

Claims (2)

少なくとも培養面が脂環構造含有重合体で構成される培養容器に、ビトロネクチン濃度が0.50〜1.20μg/mlのコート剤を用いて、少なくとも前記培養面にコーティングを施し、
該コーティングが施された前記培養容器内で人工多能性幹細胞を培養し、前記培養面に人工多能性幹細胞を接着させて内胚葉細胞へと分化誘導させる、人工多能性幹細胞の分化誘導方法。
At least the culture surface is coated using a coating agent having a vitronectin concentration of 0.50 to 1.20 μg / ml in a culture vessel in which at least the culture surface is composed of an alicyclic structure-containing polymer,
Inducing differentiation of induced pluripotent stem cells by culturing induced pluripotent stem cells in the culture vessel coated with the coating, and inducing differentiation into endoderm cells by attaching the induced pluripotent stem cells to the culture surface Method.
前記脂環構造含有重合体が、極性基を有しないものである、請求項1に記載の人工多能性幹細胞の分化誘導方法。   The method for inducing differentiation of induced pluripotent stem cells according to claim 1, wherein the alicyclic structure-containing polymer does not have a polar group.
JP2018031705A 2018-02-26 2018-02-26 Method for inducing differentiation of induced pluripotent stem cells Active JP7035616B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018031705A JP7035616B2 (en) 2018-02-26 2018-02-26 Method for inducing differentiation of induced pluripotent stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018031705A JP7035616B2 (en) 2018-02-26 2018-02-26 Method for inducing differentiation of induced pluripotent stem cells

Publications (2)

Publication Number Publication Date
JP2019146492A true JP2019146492A (en) 2019-09-05
JP7035616B2 JP7035616B2 (en) 2022-03-15

Family

ID=67848692

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018031705A Active JP7035616B2 (en) 2018-02-26 2018-02-26 Method for inducing differentiation of induced pluripotent stem cells

Country Status (1)

Country Link
JP (1) JP7035616B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020156348A (en) * 2019-03-25 2020-10-01 日本ゼオン株式会社 Method for differentiation-inducing pluripotent stem cell
WO2022039165A1 (en) * 2020-08-18 2022-02-24 東ソー株式会社 Method for inducing differentiation of pluripotent stem cells into ectodermal, mesodermal, and endodermal cells

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100273259A1 (en) * 2009-04-22 2010-10-28 Massachusetts Institute Of Technology Substrates and methods for culturing stem cells
WO2011118211A1 (en) * 2010-03-23 2011-09-29 株式会社クラレ Culture method for causing differentiation of pluripotent mammalian cells
JP2015173606A (en) * 2014-03-13 2015-10-05 富士フイルム株式会社 Composition for culture of human pluripotent stem cell, culture medium, and culture method
WO2017115706A1 (en) * 2015-12-28 2017-07-06 日本ゼオン株式会社 Method for promoting differentiation of cultured cells and cultured cell differentiation-promoting agent
JP2017525351A (en) * 2014-07-30 2017-09-07 イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. Culture medium for pluripotent stem cells

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100273259A1 (en) * 2009-04-22 2010-10-28 Massachusetts Institute Of Technology Substrates and methods for culturing stem cells
WO2011118211A1 (en) * 2010-03-23 2011-09-29 株式会社クラレ Culture method for causing differentiation of pluripotent mammalian cells
JP2015173606A (en) * 2014-03-13 2015-10-05 富士フイルム株式会社 Composition for culture of human pluripotent stem cell, culture medium, and culture method
JP2017525351A (en) * 2014-07-30 2017-09-07 イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. Culture medium for pluripotent stem cells
WO2017115706A1 (en) * 2015-12-28 2017-07-06 日本ゼオン株式会社 Method for promoting differentiation of cultured cells and cultured cell differentiation-promoting agent

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020156348A (en) * 2019-03-25 2020-10-01 日本ゼオン株式会社 Method for differentiation-inducing pluripotent stem cell
JP7268439B2 (en) 2019-03-25 2023-05-08 日本ゼオン株式会社 Method for inducing differentiation of pluripotent stem cells
WO2022039165A1 (en) * 2020-08-18 2022-02-24 東ソー株式会社 Method for inducing differentiation of pluripotent stem cells into ectodermal, mesodermal, and endodermal cells

Also Published As

Publication number Publication date
JP7035616B2 (en) 2022-03-15

Similar Documents

Publication Publication Date Title
CN106661546B (en) Method for promoting differentiation of cultured cells and cultured cell differentiation promoter
TWI675674B (en) Medical materials, cell culture method, use of fluorine-containing cyclic olefine polymer, and use of fluorine-containing cyclic olefine polymer composition
JP5867667B1 (en) Adherent cell culture method, culture vessel, and protein production method
JP7035616B2 (en) Method for inducing differentiation of induced pluripotent stem cells
JP2018201403A (en) Methods for culturing stem cells
WO2018066512A1 (en) Method for separating stem cells, method for inducing differentiation and utilization of cell culture container
JP5958658B2 (en) Method for enhancing phosphorylation of ERK or AKT in cultured cells, cell culture method, and phosphorylation enhancer
JP2018201394A (en) Methods for preparing cell sheet
JP7268439B2 (en) Method for inducing differentiation of pluripotent stem cells
JP6954121B2 (en) Method for promoting differentiation of cultured cells and agent for promoting differentiation of cultured cells
JP6973082B2 (en) Adhesive cell culture method
JP6806058B2 (en) Extracellular matrix production promoting method, cell culturing method, and extracellular matrix production promoting agent
JP7384167B2 (en) Cardiotoxicity evaluation method
WO2017104821A1 (en) Method for preparing adherent-type cells acclimated to suspension culture, method for inducing epithelial-mesenchymal transition in adherent-type epithelial cells, and use for methods
JP6716887B2 (en) Adhesive cell culture method and protein production method
JP2023062597A (en) Cardiotoxicity evaluation method
WO2018097189A1 (en) Stem cell isolation method and use of nonwoven fabric formed of norbornene-based polymer
JP2021129518A (en) Cardio toxicity evaluation method

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220106

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220201

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220214

R150 Certificate of patent or registration of utility model

Ref document number: 7035616

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150